Changing the way pharmacy only drugs are supplied would be unwiseBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h3951 (Published 23 July 2015) Cite this as: BMJ 2015;351:h3951
- Claire Anderson, vice chair, English Pharmacy Board1
- 1Royal Pharmaceutical Society, London E1W 1AW, UK
The move to change diclofenac from a pharmacy only drug to a prescription only one was based on safety issues, not poor advice being given by pharmacists.1 People’s expectations of pharmacies vary—from wanting in depth advice to selecting a product, buying it, and leaving with no questions asked. This takes place in an environment rooted in both health and commerce.2 There is an …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial